#evidence-chain

• erratum verification 20260516220426000
• mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis 20260516213747000
• PMC 参考文献下钻与 follow-up 判定 20260427023739000
• 体外与器官类系统中也未检出 senolytic→OSK 原始顺序实验 20260425224235000
• senolytic→OSK 的 ex vivo 边缘题录审稿结论 20260425192412000
• senolytic→OSK 顺序联合的原始证据边界 20260425174632000
• 骨组织中 OSK vs senolytic 的比较证据缺失边界 20260425164526000
• chronic wound failure programs clarify which senescence states are pathological 20260425033027000
• 先锁定同组织的阶段-细胞分辨图谱 20260425032914000
• acute skin wound healing contains distinct senescent subpopulations with opposite effects 20260425032856000
• partial reprogramming can improve regeneration by remodeling the extrinsic niche 20260425032418000
• senolysis before OSK may remove a pro-reprogramming niche in some contexts 20260425032136000
• 同组织 senolytic 预处理后再做 OSK 的原始实验仍未检出 20260425031957000
• senolytic 预处理与 OSK 增效证据未检出 20260425031913000
• 另一单一组织中的 senolytic→OSK 顺序组合仍未检出 20260425031525000
• 组合干预必须同时对齐顺序、组织和读出 20260425031020000
• 先固定原文再做差分 20260424224442000
• 先锁权威源再逐字对照 20260424223604000
• 先锁定权威源再逐字抽句 20260424222955000
• 先锁定权威源再逐字对照 20260424222844000
• 先抓原句边界再谈纠错范围 20260424222053000
• 先抓纠错点再补全文本 20260424221855000
• 先锁定原句，再做逐字差分 20260424221748000
• 先取原句，再判修订边界 20260424221550000
• 先拿原句再判修订边界 20260424221302000
• 先取原句再认修订 20260424221033000
• 先锁定原文再做修订对照 20260424220853000
• 先判更正范围再定引用文本 20260424220712000
• 更正只改被点名的那一句 20260424220536000
• 先拿到更正全文再判断影响 20260424220425000
• 先锁书目信息，再查更正 20260424220217000
• BOLERO-2 PMCID and abstract PFS sentence directly verified from PMC 20260424220204000
• 先锁主文再抽全字段 20260424220056000
• BOLERO-2 PMID PMCID DOI confirmed from Europe PMC and PMC 20260424220045000
• 找到主文后一次性抽全字段 20260424215932000
• BOLERO-2 主文数值与 PMID/DOI 的直接抽取（Springer OA + NCBI export） 20260424215916000
• BOLERO-2 主要终点具体结果数值（Springer OA） 20260424215736000
• BOLERO-2 可访问非-NEJM 设计/终点证据已补齐 20260424215252000
• 先用可访问二源闭环再碰受限原文 20260424215113000
• BOLERO-2 PMID 22149876 的可访问非-NEJM 设计/终点复核 20260424215102000
• BOLERO-2 PMID 22149876 的第二独立复核来源与 primary endpoint 20260424214827000
• 题录线索也要做双源闭环 20260424214532000
• BOLERO-2 原始主报告 PMID 22149876 与 primary endpoint PFS 20260424214522000
• 先判定证据层级，再找精确 PMID 20260424214413000
• PMID 22149876 is the original BOLERO-2 phase 3 primary report, not 24267730 20260424214401000
• 亚组论文不能当原始试验 20260424214200000
• PMID 24267730 is a subgroup analysis, not the first original human trial 20260424214147000
• 别在记忆里绕圈，直接打原始证据 20260424214025000
• 先判研究类型，再谈是否相关 20260424213803000
• Iter-4360dd15-0106-four-candidate-audit 20260424213752000
• 优先走可解析的证据链 20260424213650000
• Iter-4360dd15-0104-three-remaining-candidates-are-not-original-first-reports 20260424213638000
• 先验明响应格式再写解析器 20260424213353000
• Iter-4360dd15-0103-EuropePMC-38310895-reference-parser-and-candidate-shortlist 20260424213315000
• 先拿全量参考文献再分类 20260424212846000
• 先拿参考文献清单再做分类 20260424212541000
• Iter-4360dd15-0100-human-trial-vs-non-original-screening-of-38310895-references 20260424212530000
• 先抓参考文献，再做证据分层 20260424212326000
• Iter-4360dd15-0099-critic-mechanistic-vs-aging-trial 20260424212312000
• 别从落地页取证 20260424212107000
• Iter-4360dd15-0098-EuropePMC-extract-human-trial-PMIDs 20260424212055000
• 先从综述参考链落到单个原始 PMID 20260424211152000
• 先从参考链锁定单个原始试验 20260424210848000
• 先从综述引用链提取唯一原始 PMID 20260424210659000
• 先锁定唯一 PMID 再判终点 20260424210407000
• 先锁定唯一引用再看终点 20260424210210000
• 先从综述引用链落到原始试验 20260424210023000
• 先从综述引用链下钻到原始试验 20260424205810000
• 先锁定原始试验再谈终点 20260424205610000